News Conference News TVT 2016 When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care Michael O'Riordan June 20, 2016
News Conference News TCT 2015 First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible October 12, 2015
News Conference News TCT 2014 PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients Yael L. Maxwell September 13, 2014
News Conference News TCT 2013 TCT Honors Bernhard Meier with the Hartzler Master Clinical Operator Award October 30, 2013
News Conference News PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years November 09, 2011
News Conference News BRAVO: Fewer Adverse Events with Bivalirudin vs. Heparin After Aortic Valvuloplasty November 07, 2011
News Conference News PARTNER: TAVI Cost Effective Compared With Standard Care Jason Kahn April 03, 2011